Curated News
By: NewsRamp Editorial Staff
June 11, 2025
INBS and SMARTOX Drive Growth in Non-Invasive Drug Testing Market
TLDR
- Intelligent Bio Solutions Inc. (NASDAQ: INBS) gains a competitive edge in the U.S. Forensic Use Only Market through its alliance with SMARTOX, showcasing the demand for its innovative drug screening technology.
- INBS's fingerprint sweat-based drug screening system offers a rapid, non-invasive alternative to traditional tests, with over 7,000 tests conducted, highlighting its efficiency and ease of use.
- The deployment of INBS's Intelligent Fingerprinting Drug Screening Readers improves dignity and efficiency in drug testing, contributing to safer and more humane corrections and rehabilitation environments.
- Discover how INBS's cutting-edge fingerprint sweat analysis technology is transforming drug testing with over 1,500 tests in 2024 alone, offering a glimpse into the future of non-invasive diagnostics.
Impact - Why it Matters
This news highlights a significant advancement in drug testing technology, offering a less invasive, more dignified, and efficient alternative to traditional methods. For employers, especially in safety-critical industries, this could mean quicker, more reliable drug screening processes, enhancing workplace safety. For individuals undergoing testing, it represents a shift towards more respectful and convenient methods. The expansion into workplace drug testing could set new standards in how drug use is monitored across various sectors, impacting millions of workers and employers globally.
Summary
Intelligent Bio Solutions Inc. (NASDAQ: INBS), in partnership with SMARTOX, a Texas-based leader in drug and alcohol screening services, has reported significant growth in the U.S. Forensic Use Only Market. The collaboration has led to the deployment of over 50 INBS Intelligent Fingerprinting Drug Screening Readers and the conduction of more than 7,000 tests, showcasing the increasing demand for INBS's innovative, non-invasive testing solution. This technology, which utilizes fingerprint sweat for drug detection, offers a more efficient and dignified alternative to traditional urine and saliva tests, particularly beneficial in corrections, rehabilitation, and drug court settings. INBS is also advancing towards FDA clearance for its codeine opiate test, with ambitions to penetrate the workplace drug testing market later this year.
For more details, visit the full article. Intelligent Bio Solutions Inc. is at the forefront of revolutionizing portable drug testing through its Intelligent Fingerprinting Drug Screening System, aiming to expand its applications beyond the current markets. The company's technology is designed for quick and hygienic drug screening, targeting substances like opiates, cocaine, methamphetamine, and cannabis, with results available in under ten minutes. This positions INBS as a potential game-changer for employers in safety-critical industries seeking reliable and efficient drug testing solutions.
Source Statement
This curated news summary relied on content disributed by InvestorBrandNetwork (IBN). Read the original source here, INBS and SMARTOX Drive Growth in Non-Invasive Drug Testing Market
